NCT00205075已完成不适用
The Use of Validated Measures of Alcohol Intake to Measure the Impact of Moderate Alcohol Consumption on Hepatic Fibrogenesis in Individuals Infected With Hepatitis C
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 47
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to determine the effect of moderate alcohol intake on liver disease caused by HCV in terms of speed of progression as compared to those not drinking alcohol.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Outpatient with HCV who is not receiving or planning treatment but is receiving standard of care monitoring every 3 months and is either abstinent from alcohol or drinking only moderately
排除标准
- •HIV co-infection
- •Treated within the past 6 months
- •History (hx) of other liver disease
- •Alcohol use greater than 30 g/day or history of binge drinking in the last year
- •Decompensated liver disease
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Hepatic Function During and Following Three Days of Acetaminophen Dosing in AlcoholicsAlcohol Related DisordersNCT00402571Denver Health and Hospital Authority420
已完成
不适用
Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment TrialAlcohol-Related DisordersLiver DiseasesNCT04473482University of Michigan60
招募中
不适用
Evaluating Alcohol Use in Alcoholic Liver DiseaseAlcoholic Liver DiseaseNCT03267069Nicole T Shen160
招募中
不适用
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) PatientsAlcohol-related Liver DiseaseLiver DiseasesNCT06269510Henry Ford Health System268
已完成
1 期
Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionHealthyLiver DiseasesNCT02171832Boehringer Ingelheim32